Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248393560> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4248393560 endingPage "58" @default.
- W4248393560 startingPage "58" @default.
- W4248393560 abstract "Enhancer of zeste homolog 2 (EZH2), a member of the polycomb group proteins, has been shown to promote cancer progression and breast cancer stem cell (CSC) expansion. Breast CSCs are associated with resistance to radiation in inflammatory breast cancer (IBC), a rare but aggressive variant of breast cancer. In this retrospective study, we examined the clinical role of EZH2 in locoregional recurrence (LRR) of IBC patients treated with radiation. 62 IBC patients who received radiation (7 pre-operative, 55 post-operative) and had adequate follow up to assess LRR were the subject of this study. Positive EZH2 status was defined as nuclear immunohistochemical staining in at least 10% of invasive cancer cells. Association of EZH2 expression with clinicopathologic features were evaluated using the Chi-square statistic and actuarial LRR free survival (LRFS) was determined using the Kaplan-Meier method. The median follow-up for this cohort was 33.7 months, and the 5-year overall LRFS rate was 69%. Of the 62 patients, 16 (25.8%) had LRR, and 15 out of 16 LRR occurred in EZH2 expressing cases. Univariate analysis indicated that patients who had EZH2-positive IBC had a significantly lower 5-year locoregional free survival (LRFS) rate than patients who had EZH2-negative IBC (93.3% vs. 59.1%; P = 0.01). Positive EZH2 expression was associated significantly with negative ER status (97.1% in ER- vs 48.1% in ER+; P < 0.0001) and triple-negative receptor status (P = 0.0001) and all triple-negative tumors were EZH2-positive. In multivariate analysis, only triple negative status remained an independent predictor of worse LRFS (hazard ratio 5.64, 95% CI 2.19 – 14.49, P < 0.0001). EZH2 correlates with locoregional recurrence in IBC patients who received radiation treatment. EZH2 expression status may be used in addition to receptor status to identify a subset of patients with IBC who recur locally in spite of radiation and may benefit from enrollment in clinical trials testing radiosensitizers." @default.
- W4248393560 created "2022-05-12" @default.
- W4248393560 creator A5003107322 @default.
- W4248393560 creator A5016731809 @default.
- W4248393560 creator A5026491661 @default.
- W4248393560 creator A5045166646 @default.
- W4248393560 creator A5060592779 @default.
- W4248393560 creator A5073488441 @default.
- W4248393560 creator A5080832682 @default.
- W4248393560 creator A5081939632 @default.
- W4248393560 creator A5088293773 @default.
- W4248393560 creator A5088814426 @default.
- W4248393560 date "2014-01-01" @default.
- W4248393560 modified "2023-10-14" @default.
- W4248393560 title "EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer" @default.
- W4248393560 doi "https://doi.org/10.1186/preaccept-1927311006127694" @default.
- W4248393560 hasPublicationYear "2014" @default.
- W4248393560 type Work @default.
- W4248393560 citedByCount "0" @default.
- W4248393560 crossrefType "journal-article" @default.
- W4248393560 hasAuthorship W4248393560A5003107322 @default.
- W4248393560 hasAuthorship W4248393560A5016731809 @default.
- W4248393560 hasAuthorship W4248393560A5026491661 @default.
- W4248393560 hasAuthorship W4248393560A5045166646 @default.
- W4248393560 hasAuthorship W4248393560A5060592779 @default.
- W4248393560 hasAuthorship W4248393560A5073488441 @default.
- W4248393560 hasAuthorship W4248393560A5080832682 @default.
- W4248393560 hasAuthorship W4248393560A5081939632 @default.
- W4248393560 hasAuthorship W4248393560A5088293773 @default.
- W4248393560 hasAuthorship W4248393560A5088814426 @default.
- W4248393560 hasBestOaLocation W42483935601 @default.
- W4248393560 hasConcept C104317684 @default.
- W4248393560 hasConcept C121608353 @default.
- W4248393560 hasConcept C126322002 @default.
- W4248393560 hasConcept C143998085 @default.
- W4248393560 hasConcept C144301174 @default.
- W4248393560 hasConcept C150194340 @default.
- W4248393560 hasConcept C204232928 @default.
- W4248393560 hasConcept C2778740770 @default.
- W4248393560 hasConcept C2779013556 @default.
- W4248393560 hasConcept C2780110267 @default.
- W4248393560 hasConcept C38180746 @default.
- W4248393560 hasConcept C50171091 @default.
- W4248393560 hasConcept C530470458 @default.
- W4248393560 hasConcept C55493867 @default.
- W4248393560 hasConcept C71924100 @default.
- W4248393560 hasConcept C86803240 @default.
- W4248393560 hasConceptScore W4248393560C104317684 @default.
- W4248393560 hasConceptScore W4248393560C121608353 @default.
- W4248393560 hasConceptScore W4248393560C126322002 @default.
- W4248393560 hasConceptScore W4248393560C143998085 @default.
- W4248393560 hasConceptScore W4248393560C144301174 @default.
- W4248393560 hasConceptScore W4248393560C150194340 @default.
- W4248393560 hasConceptScore W4248393560C204232928 @default.
- W4248393560 hasConceptScore W4248393560C2778740770 @default.
- W4248393560 hasConceptScore W4248393560C2779013556 @default.
- W4248393560 hasConceptScore W4248393560C2780110267 @default.
- W4248393560 hasConceptScore W4248393560C38180746 @default.
- W4248393560 hasConceptScore W4248393560C50171091 @default.
- W4248393560 hasConceptScore W4248393560C530470458 @default.
- W4248393560 hasConceptScore W4248393560C55493867 @default.
- W4248393560 hasConceptScore W4248393560C71924100 @default.
- W4248393560 hasConceptScore W4248393560C86803240 @default.
- W4248393560 hasIssue "1" @default.
- W4248393560 hasLocation W42483935601 @default.
- W4248393560 hasLocation W42483935602 @default.
- W4248393560 hasOpenAccess W4248393560 @default.
- W4248393560 hasPrimaryLocation W42483935601 @default.
- W4248393560 hasRelatedWork W1905605175 @default.
- W4248393560 hasRelatedWork W1966181922 @default.
- W4248393560 hasRelatedWork W1999292713 @default.
- W4248393560 hasRelatedWork W2048873934 @default.
- W4248393560 hasRelatedWork W2339918942 @default.
- W4248393560 hasRelatedWork W2554176272 @default.
- W4248393560 hasRelatedWork W2892287597 @default.
- W4248393560 hasRelatedWork W2999610670 @default.
- W4248393560 hasRelatedWork W3160736738 @default.
- W4248393560 hasRelatedWork W80971072 @default.
- W4248393560 hasVolume "33" @default.
- W4248393560 isParatext "false" @default.
- W4248393560 isRetracted "false" @default.
- W4248393560 workType "article" @default.